He Y - Search Results

1

Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma.

Zhang H, Chen J, Meng Y, Cen Q, Wang H, Ding X, Ai K, Yang Y, Gao Y, Qiu Y, Hu Y, Li M, He Y, Li Y. Zhang H, et al. Among authors: he y. Cancer Gene Ther. 2024 Nov 7. doi: 10.1038/s41417-024-00845-w. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39511416

2

Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma.

Zhang H, Wang H, Hu Y, Gao Y, Chen J, Meng Y, Qiu Y, Hu R, Liao P, Li M, He Y, Liang Z, Xie X, Li Y. Zhang H, et al. Among authors: he y. Cancer Lett. 2024 Apr 28;588:216802. doi: 10.1016/j.canlet.2024.216802. Epub 2024 Mar 11. Cancer Lett. 2024. PMID: 38467180

3

Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma.

Xie X, Chen Y, Hu Y, He Y, Zhang H, Li Y. Xie X, et al. Among authors: he y. Mol Cancer Ther. 2019 Dec;18(12):2258-2269. doi: 10.1158/1535-7163.MCT-19-0424. Epub 2019 Aug 14. Mol Cancer Ther. 2019. PMID: 31413179

4

EPS8-mediated regulation of multiple myeloma cell growth and survival.

Zhang H, Zhou L, Zhou W, Xie X, Wu M, Chen Y, Hu Y, Du J, He Y, Li Y. Zhang H, et al. Among authors: he y. Am J Cancer Res. 2019 Aug 1;9(8):1622-1634. eCollection 2019. Am J Cancer Res. 2019. PMID: 31497346 Free PMC article.

5

Loss of EPS8 sensitizes non-small-cell lung carcinoma to chemotherapy-induced DNA damage.

Qiu Y, Xu B, Feng J, Wang C, Chen Y, He Y, Xie X, Li Y. Qiu Y, et al. Among authors: he y. Cancer Gene Ther. 2023 Jul;30(7):997-1006. doi: 10.1038/s41417-023-00606-1. Epub 2023 Mar 17. Cancer Gene Ther. 2023. PMID: 36932195

6

Inhibition of Tumoral VISTA to Overcome TKI Resistance via Downregulation of the AKT/mTOR and JAK2/STAT5 Pathways in Chronic Myeloid Leukemia.

Ai K, Chen M, Liang Z, Ding X, Gao Y, Zhang H, Wu S, He Y, Li Y. Ai K, et al. Among authors: he y. Biomol Ther (Seoul). 2024 Sep 1;32(5):582-600. doi: 10.4062/biomolther.2024.017. Epub 2024 Aug 6. Biomol Ther (Seoul). 2024. PMID: 39104205 Free PMC article.

7

Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities.

Chen Y, Xie X, Wang C, Hu Y, Zhang H, Zhang L, Tu S, He Y, Li Y. Chen Y, et al. Among authors: he y. Cell Death Dis. 2020 Sep 1;11(8):712. doi: 10.1038/s41419-020-02885-0. Cell Death Dis. 2020. PMID: 32873786 Free PMC article.

8

Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms.

Chen J, Zhang H, Zhou L, Hu Y, Li M, He Y, Li Y. Chen J, et al. Among authors: he y. Front Oncol. 2021 Feb 3;10:584367. doi: 10.3389/fonc.2020.584367. eCollection 2020. Front Oncol. 2021. PMID: 33614478 Free PMC article. Review.

9

Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia.

Chang N, Feng J, Liao P, Hu Y, Li M, He Y, Li Y. Chang N, et al. Among authors: he y. Transl Cancer Res. 2023 Feb 28;12(2):287-300. doi: 10.21037/tcr-22-1778. Epub 2023 Feb 1. Transl Cancer Res. 2023. PMID: 36915581 Free PMC article.

10

[Advancement of peptide vaccines for hematologic malignancies].

Zhou WJ, He YJ, Li YH. Zhou WJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1512-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 22169315 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,889 results

Search Page

Filters